Table 3. Comparison of Age-standardized Detection Rates of cancer in the ICS Screening Population (2011-12) and Estimated Age-standardized Incidence Rates of New Delhi Cancer Registry (2012) and India (GloboCan 2012).
| ASR/100,000 | Women | Men | ||||
|---|---|---|---|---|---|---|
| For all ages | ICS ASDR |
New Delhi ASR** ASR† |
India ASDR |
ICS ASR† |
New Delhi ASR** | India |
| Oral cancer | 26.4 | 5.8 | 4.3 | 239.4 | 16.9 | 10.1 |
| Breast cancer | 195.3 | 22 | 25.8 | - | - | - |
| Gynecological cancer (corpus uteri and cervix) | 47.4 | 7.5 | - | - | - | |
| All sites | 329.8* | 70.3 | 97.4 | 340.8* | 172.1 | 92.4 |
*
All sites (for ICS) in men include urinary bladder (n=1); larynx (n=2); leukemia (n=1); tonsil (n=2) and neck (n=1) and all sites in women include gall bladder (n=1); urinary bladder (n=1) and neck (n=1)
**
New Delhi estimated ASR (incidence rate) for the year 2012 based on 2001-2011 census population, New Delhi PBCR data in 2008-2009, and linear extrapolation of changing incidence rates and census population
†
GloboCan estimated ASR (incidence rate) for 2012; ASDR - Age-standardized detection rates; ASR- Age-standardized incidence rates